By Plenary Sessions: Tanel Kiik

Strongly supports the promotion of free competition in the pharmaceutical market and the dismantling of the oligopolistic market structure. It argues that the state should not be involved in promoting the business interests of individual companies, but should instead focus on patient health and the availability of medicines. It advocates granting hospitals additional rights for the direct import of medicines to reduce the monopolistic position of wholesalers and increase competition, which, in its estimation, will drive down drug prices.

He delivered a comprehensive speech on the state budget, stressing the need for a progressive income tax and a fairer distribution of the tax burden. He criticized the current tax system as regressive.

He/She addressed the amendments to the Competition Act, emphasizing the necessity of protecting consumers and ensuring fair competition. He/She criticized the fostering of an oligopolistic market through legislative changes.

There is not enough data.